Emma M Kerr

7PUBLICATIONS
50CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 23, 2026
Mitochondrial metabolism determines chemotherapy sensitivity in colorectal cancer.

|Jul 28, 2025
Inhibition of HDAC6 alters fumarate hydratase activity and mitochondrial structure.

Andrew Roe, Catríona M Dowling, Cian D'Arcy

|Jun 03, 2024
Author Correction: Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer.

Sudhir B Malla, Ryan M Byrne, Maxime W Lafarge

|Feb 14, 2024
Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer.

Sudhir B Malla, Ryan M Byrne, Maxime W Lafarge

|Jan 31, 2023
Author Correction: Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features.

Dustin J Flanagan, Raheleh Amirkhah, David F Vincent

|Dec 08, 2022
Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features.

Dustin J Flanagan, Raheleh Amirkhah, David F Vincent

Pageof 2

Frequent Collaborators

5 joint publications

Philip D Dunne

5 joint publications

Owen Sansom

4 joint publications

Rachel A Ridgway

4 joint publications

Andrew D Campbell